Day 2 of our exhibition at ASM Microbe is underway, and we’re energized by the connections from Day 1. Want to learn more about our award-winning single-cell microbiology testing platform? Drop by booth #825 for a live demo and chat with our team.
Pattern Bioscience
Biotechnology Research
Austin, Texas 3,606 followers
Our mission is simple: We will improve the world's most important health decisions.
About us
Tackling a global health threat like antimicrobial resistance is not for the faint of heart, but the experienced and innovative team at Pattern Bioscience is on a mission to do it. Each year, drug-resistant bacterial infections claim more than a million lives globally and cost our healthcare system billions of dollars. Traditional diagnostic methods for bacterial infections remain rooted in slow, cumbersome, decades-old technology that contributes to sub-optimal treatment and the misuse of broad-spectrum antibiotics. The Pattern system is different. We’re developing the world’s only culture-free, rapid diagnostic technology that will reduce the time needed for pathogen identification (ID) and antibiotic susceptibility test (AST) results from days to hours. Our technology combines single-cell analysis of microorganisms with machine learning tools to deliver fast, clinically actionable information. The result? Patients get the right treatment faster, to save lives, prevent side effects and reduce healthcare costs.
- Website
-
https://pattern.bio
External link for Pattern Bioscience
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Austin, Texas
- Type
- Privately Held
- Founded
- 2016
Locations
-
Primary
Get directions
Austin, Texas 78759, US
Employees at Pattern Bioscience
Updates
-
Interested in our cutting-edge single-cell microbiology technology? Join Carey-Ann Burnham this Friday at 5:15pm at ASM Microbe for a spotlight discussion on our award-winning innovation.
-
-
Pattern Bioscience reposted this
Meet the Forty Acres Founders Pitch Competition Judges Panel! 🚀💡 NICK ARAB - Co-Founder & CEO of Pattern Bioscience Nick is the co-founder and CEO of Pattern Bioscience, an Austin-based med-tech startup developing a single-cell microbiology platform to solve antibiotic resistance. Under his guidance, Pattern has raised $68 million, including almost $50 million over multiple equity financings. Nick has over 15 years of experience developing FDA-cleared diagnostic products and technologies. Before founding Pattern in 2016, Nick was at Luminex for 10 years, most recently serving as Senior Director of the company’s Advanced Technology Group. He has innovated across several technical disciplines, twice winning Luminex’s “Top Inventor” award, and has been granted 39 patents with 37 patents pending. Nick obtained his B.S. in Electrical Engineering at UT Austin. Come see what questions Nick has for the founders at the Forty Acres Founders Pitch Competition Finals on April 18th! RSVP today: https://bit.ly/49YV7Pq #FortyAcresFounders #StartupsStartHere #PitchCompetition
-
-
Pattern Bioscience reposted this
Pattern Bioscience, the winner of the 2023 Disruptive Technology Award, combines AI and novel microfluidics for single-cell microbiology. https://ow.ly/6VuK50QhoHh
-
-
Looking for an overview on how we’re tackling antibiotic resistance with our award-winning single-cell microbiology technology? The Association for Diagnostics & Laboratory Medicine has you covered with their recent article, featuring some insightful excerpts from Carey-Ann Burnham.
-
Antibiotic resistance is fueled in part by the days-long wait for culture-based tests. During this waiting period, providers often use broad-spectrum antibiotics to avoid treatment failure, inadvertently promoting overuse and misuse of antibiotics. Our solution? Provide same-day phenotypic antibiotic susceptibility results that guide healthcare providers in choosing targeted antibiotics quickly and confidently. #WAAW23 #AMR
-
-
There’s currently no rapid diagnostic test for #Pneumonia that provides same-day phenotypic antibiotic susceptibility results. We aim to address this unmet need to help ensure that patients receive the most targeted antibiotic treatment in a timely manner. #WorldPneumoniaDay
-
-
Join us this International Infection Prevention Week as we recognize and celebrate infection prevention professionals for the work they do to keep our healthcare facilities safe by preventing the spread of #SuperBugs. We’d like to especially recognize a few IPs we know: Helen Wood, Rachael Snyders, and Kelly Fieleke, we thank you! #InfectionPrevention #IIPW23
-